序号 |
标题 |
次数 |
作者 |
发布时间 |
85501 |
N-(2-氯代异丁酰氯基)-顺-5-降冰片烯-外-2,3-二甲酰亚胺 exo-CNDI |
159 |
h |
2024-11-29 |
85502 |
DOTA-tris(acid)-amido-dPEG-bromoacetamide DOTA-酸性酰胺-离散聚乙二醇-溴乙酰胺 |
188 |
zcy |
2024-11-29 |
85503 |
降冰片烯二酸酐-马来酰亚胺基七异丁基POSS交替共聚物 P(NA-alt-MIPOSS) |
196 |
h |
2024-11-29 |
85504 |
环氧降冰片烷 EPO-NBE |
247 |
h |
2024-11-29 |
85505 |
NOTA-SPM 大环配体DOTA修饰SPM探针 |
90 |
zyl |
2024-11-29 |
85506 |
74389-69-8;C18-02:0 PC;血小板活化因子(C18) |
271 |
kx |
2024-11-29 |
85507 |
2-氨基金刚烷(2-NH2-Adam) |
162 |
h |
2024-11-29 |
85508 |
多肽修饰四氮杂环十二烷四乙酸(DOTA)的方法 |
213 |
zcy |
2024-11-29 |
85509 |
NH2-DOTA-GA , 有氨基的DOTA衍生物 |
129 |
wyh |
2024-11-29 |
85510 |
4-(1-金刚烷基)-1,3-二苯酚(ADRL) |
134 |
h |
2024-11-29 |
85511 |
N,N,N-三甲基-1-金刚烷基季铵盐 |
256 |
h |
2024-11-29 |
85512 |
NH2-DOTA-GA ,氨基-大环配体-甘草次酸 ,1639843-65-4 |
114 |
wyh |
2024-11-29 |
85513 |
NOTA-RGD-ATWLPPR NOTA-NHS活化酯偶联双靶点分子探针RGD-ATWLPPR |
143 |
zyl |
2024-11-29 |
85514 |
1,3-二(4-羟苯基)金刚烷(DPAD) |
183 |
h |
2024-11-29 |
85515 |
CAS:1027160-33-3 FITC-PEG2-TATE |
199 |
zcy |
2024-11-29 |
85516 |
97802-55-6;C18(Plasm) LPC; |
192 |
kx |
2024-11-29 |
85517 |
250612-06-7 , DOTA-E[CYCLO(RGDFK)]2探针多肽 |
115 |
wyh |
2024-11-29 |
85518 |
NOTA/NODAGA NOTA偶联NODAGA环状多肽 |
155 |
zyl |
2024-11-29 |
85519 |
1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid, α10-(2-carboxyethyl)-, 1,4,7,10-tetrakis(1,1-dimethylethyl) ester, (α1S)- 定制 |
134 |
zcy |
2024-11-29 |
85520 |
DOTA-NHS DOTA-N-羟基琥珀酰亚胺酯 |
263 |
zcy |
2024-11-29 |
85521 |
NOTA-yG5-RGD NOTA修饰小分子环肽cyclo偶联c(RGDyK) |
122 |
zyl |
2024-11-29 |
85522 |
DOTA-E[cyclo(RGDfK)2] |
201 |
wyh |
2024-11-29 |
85523 |
CAS:170908-81-3 DOTA-活性酯 |
256 |
zcy |
2024-11-29 |
85524 |
C18-PEG12-COOH的分子结构、优势 |
159 |
kx |
2024-11-29 |
85525 |
钆特酸 72573-82-1 Gd-DOTA |
196 |
wyh |
2024-11-29 |
85526 |
2,2,4,4-四硝基金刚烷 |
121 |
h |
2024-11-29 |
85527 |
G2-NOTA(Mn2+)-PEG-RGD NOTA功能化低代树状大分子纳米材料 |
161 |
zyl |
2024-11-29 |
85528 |
N-[[4,7,10-三(羧甲基)-1,4,7,10-四氮杂环十二烷-1-基]乙酰基]-D-苯丙氨酰基-L-半胱氨酰基-L-酪氨酰基-D-色氨酰基-L-赖氨酰基-L-苏氨酰基-L-半胱氨酰基-L-苏氨酸, 环(2→7)-二硫化物 |
255 |
zcy |
2024-11-29 |
85529 |
金刚烷-1,3,5,7-四对苯三聚氰胺磺酸盐 |
198 |
h |
2024-11-29 |
85530 |
DOTA-GA(tBu)4 ;DOTAGA-tetra (t-Bu ester) |
145 |
wyh |
2024-11-29 |
85531 |
DOTA-三(酸) - 酰氨基-DPEG(R)11-马来酰亚胺 DOTA-tris(acid)-amido-dPEG (R)11-Maleimide |
184 |
zcy |
2024-11-29 |
85532 |
NOTA-PEG4-cRGD2 NOTA-四聚乙二醇-cRGD2环肽 |
143 |
zyl |
2024-11-29 |
85533 |
DOTAGlu-C(AGADPL)2 ; 250612-06-7 |
108 |
wyh |
2024-11-29 |
85534 |
4-Quinolinecarboxamide, N-[2-[(2S)-2-cyano-4,4-difluoro-1-pyrrolidinyl]-2-oxoethyl]-6-[3-(1-piperazinyl)propoxy]- 定制 |
141 |
zcy |
2024-11-29 |
85535 |
NOTA-octreotide NOTA-奥曲肽 大环配体NOTA偶联奥曲肽 |
152 |
zyl |
2024-11-29 |
85536 |
NOTA-Exendin4 NOTA-艾塞那肽 |
155 |
zyl |
2024-11-29 |
85537 |
CAS:1262311-97-6 大环化合物 |
183 |
zcy |
2024-11-29 |
85538 |
荧光增强型四嗪生物正交荧光探针 |
265 |
WYQ |
2024-11-29 |
85539 |
靶向对比剂 CREKA-(Gd-DOTA)4 |
160 |
wyh |
2024-11-29 |
85540 |
NOTA-PEG6-TATE 大环NOTA-六聚乙二醇-奥曲肽 |
127 |
zyl |
2024-11-29 |
85541 |
四嗪共轭修饰萘环(Tz-Naphthalene) |
198 |
WYQ |
2024-11-29 |
85542 |
C18-PEGn-OH的分子结构、特性与应用 |
165 |
kx |
2024-11-29 |
85543 |
四嗪标记探针TNO是一种基于四嗪结构的探针分子 |
150 |
WYQ |
2024-11-29 |
85544 |
NOTA-多肽-PEG11-Tz NOTA-多肽-十一聚乙二醇-四嗪 |
153 |
zyl |
2024-11-29 |
85545 |
3-氨基-6-三氟甲基-1,2,4,5-四嗪-1,5-二氧化物(Ⅷ) |
165 |
WYQ |
2024-11-29 |